InflaRx (IFRX) Stock Chart & Stock Price History → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free IFRX Stock Alerts $1.19 -0.01 (-0.83%) (As of 11:57 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media InflaRx Stock Price Performance5 Day Performance-13.77%1 Month Performance-26.54%3 Month Performance-21.71%6 Month Performance-9.85%Year-To-Date Performance-26.99%1 Year Performance-72.20% Receive IFRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… IFRX Stock Chart for Thursday, May, 9, 2024 IFRX Chart by TradingView InflaRx Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$1.24$1.20-3.23%$1.29$1.17264,912 shs$70.66 million05/07/2024$1.30$1.24-4.25%$1.32$1.21187,159 shs$73.01 million05/06/2024$1.38$1.30-6.16%$1.41$1.28236,410 shs$76.25 million05/03/2024$1.38$1.38$1.45$1.28179,353 shs$81.25 million05/02/2024$1.41$1.38-2.13%$1.43$1.30143,015 shs$81.25 million05/01/2024$1.37$1.41+2.92%$1.43$1.33184,265 shs$83.02 million Get the Latest News and Ratings for IFRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$1.39$1.37-1.44%$1.44$1.3437,668 shs$80.67 million04/29/2024$1.33$1.39+4.51%$1.45$1.32170,346 shs$81.84 million04/26/2024$1.39$1.33-4.32%$1.43$1.28169,301 shs$78.31 million04/25/2024$1.36$1.39+2.21%$1.41$1.26146,063 shs$81.85 million04/24/2024$1.36$1.36$1.43$1.3371,453 shs$80.08 million04/23/2024$1.37$1.36-0.73%$1.46$1.3297,199 shs$80.08 million04/22/2024$1.35$1.37+1.48%$1.41$1.31115,749 shs$80.67 million04/19/2024$1.26$1.35+7.14%$1.38$1.27136,141 shs$79.49 million04/18/2024$1.27$1.26-0.40%$1.42$1.25120,599 shs$74.19 million04/17/2024$1.31$1.27-3.44%$1.34$1.24274,068 shs$74.48 million04/16/2024$1.39$1.31-5.76%$1.41$1.25178,127 shs$77.13 million04/15/2024$1.50$1.39-7.33%$1.50$1.37145,859 shs$81.84 million04/12/2024$1.54$1.50-2.60%$1.55$1.45223,615 shs$88.32 million04/11/2024$1.52$1.54+1.32%$1.65$1.51114,727 shs$90.68 million04/10/2024$1.62$1.52-6.17%$1.66$1.51932,330 shs$89.50 million04/09/2024$1.52$1.62+6.58%$1.66$1.46453,358 shs$95.39 million04/08/2024$1.55$1.52-1.94%$1.64$1.5180,452 shs$89.50 million04/05/2024$1.56$1.55-0.64%$1.68$1.50365,160 shs$91.26 million04/04/2024$1.55$1.56+0.65%$1.60$1.50140,064 shs$91.85 million04/03/2024$1.54$1.55+0.65%$1.66$1.52220,672 shs$91.26 million04/02/2024$1.52$1.54+1.32%$1.58$1.5156,341 shs$90.68 million04/01/2024$1.54$1.52-1.30%$1.59$1.5149,940 shs$67.95 million03/29/2024$1.54$1.54$1.57$1.51317,780 shs$68.84 million03/28/2024$1.54$1.54$1.57$1.51317,779 shs$68.84 million03/27/2024$1.54$1.54$1.60$1.52190,094 shs$68.84 million03/26/2024$1.54$1.54$1.60$1.5295,978 shs$68.84 million03/25/2024$1.49$1.54+3.36%$1.61$1.50147,155 shs$68.84 million03/22/2024$1.54$1.49-3.25%$1.59$1.49396,522 shs$66.60 million03/21/2024$1.69$1.54-8.88%$1.70$1.40624,665 shs$68.84 million03/20/2024$1.69$1.69$1.75$1.64239,499 shs$75.54 million03/19/2024$1.50$1.69+12.67%$1.82$1.54254,597 shs$75.54 million03/18/2024$1.58$1.50-5.06%$1.57$1.50149,419 shs$67.05 million03/15/2024$1.52$1.58+3.95%$1.62$1.49123,809 shs$70.63 million03/14/2024$1.58$1.52-3.80%$1.57$1.4891,755 shs$67.94 millionThis 1 Biotech Stock has been shocking the markets (Ad)Save the Date: BioStem's 2024 Q1 Call Coming Up!Sign Up for the Live Broadcast here03/13/2024$1.57$1.58+0.64%$1.62$1.5667,055 shs$70.63 million03/12/2024$1.62$1.57-3.09%$1.69$1.56120,561 shs$70.19 million03/11/2024$1.62$1.62$1.72$1.57170,802 shs$72.41 million03/08/2024$1.66$1.62-2.41%$1.74$1.6253,125 shs$72.41 million03/07/2024$1.74$1.66-4.60%$1.76$1.64142,813 shs$74.21 million03/06/2024$1.79$1.74-2.79%$1.84$1.72191,291 shs$77.78 million03/05/2024$1.77$1.79+1.13%$1.82$1.7298,366 shs$80.01 million03/04/2024$1.75$1.77+1.14%$1.90$1.67341,128 shs$79.12 million03/01/2024$1.78$1.75-1.69%$1.88$1.70367,473 shs$78.23 million02/29/2024$1.74$1.78+2.30%$1.92$1.71263,193 shs$79.57 million02/28/2024$1.65$1.74+5.45%$1.76$1.59376,526 shs$77.78 million02/27/2024$1.50$1.65+10.00%$1.73$1.481.00 million shs$73.76 million02/26/2024$1.51$1.50-0.66%$1.55$1.49236,565 shs$67.05 million02/23/2024$1.47$1.51+2.72%$1.54$1.40456,366 shs$67.50 million02/22/2024$1.51$1.47-2.65%$1.55$1.46227,452 shs$65.72 million02/21/2024$1.53$1.51-1.31%$1.55$1.4993,527 shs$67.50 million02/20/2024$1.55$1.53-1.29%$1.57$1.50111,631 shs$68.39 million02/19/2024$1.55$1.55$1.58$1.51465,100 shs$69.29 million02/16/2024$1.54$1.55+0.65%$1.58$1.51465,143 shs$69.29 million02/15/2024$1.47$1.54+4.76%$1.60$1.49174,483 shs$68.84 million02/14/2024$1.58$1.47-6.96%$1.62$1.47637,104 shs$65.71 million02/13/2024$1.65$1.58-4.24%$1.70$1.56278,883 shs$70.63 million02/12/2024$1.52$1.65+8.55%$1.72$1.54841,903 shs$73.76 million02/09/2024$1.58$1.52-3.80%$1.65$1.52126,677 shs$67.94 million02/08/2024$1.57$1.58+0.64%$1.70$1.57201,117 shs$70.63 million Related Companies: Affimed Stock Chart Barinthus Biotherapeutics Stock Chart Leap Therapeutics Stock Chart Vaccitech Stock Chart LifeVantage Stock Chart BeyondSpring Stock Chart ProPhase Labs Stock Chart Genelux Stock Chart Oncolytics Biotech Stock Chart Chimerix Stock Chart Receive IFRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IFRX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InflaRx Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.